Akimoto M, Miyazaki T, Takahashi H, Saigusa Y, Takeda T, Hibino Y, Tokunaga M, Ohashi T,
Matsumura A, Teshigawara H, Suzuki T, Teranaka H, Nakajima Y, Matsumoto K, Hashimoto C, Fujimaki K, Fujita H, Sakai R, Fujisawa S, Nakajima H：Comparison of standardized prophylactic high-dose and intrathecal methotrexate for DLBCL with a high risk of CNS relapse．Int J Hematol，119(2)：164-172，2024．
Arai S, Tachibana T, Izumi A, Takeda T, Tamai Y, Sato S, Hashimoto C, Fujimaki K, Ishii R,
Kabasawa N, Hirasawa A, Inoue Y, Tanaka M, Suzuki T, Nakajima H：WT1-guided pre-emptive therapy after allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia．Int J Hematol．120(3)：337-346，2024．
Hibino Y, Sakai R, Takahashi H, Takeda T, Hirose N, Tokunaga M, Washimi K, Yokose T, Kasajima
R, Hiroshima Y, Miyagi Y, Nakajima H：Efficacy of Combined Encorafenib and Binimetinib Treatment for Erdheim-Chester Disease Harboring Concurrent BRAFV600E and KRASG12R Mutations: A Case Report．Cancer Rep (Hoboken)，7(12)：e70093，2024．
Katsuki K, Tachibana T, Izumi A, Kim K, Suzuki T, Tanaka M, Nakajima H：Acute mixed-lineage
leukemia treated with desensitization therapy prior to HLA-haploidentical transplantation with high donor-specific antibodies．Int J Hematol，120(2)：256-261，2024．
Kunimoto H, Sakuma T, Ohashi T, Shirafuta M, Teranaka H, Nakajima H：Successful treatment of
low-risk myelodysplastic syndrome-related anemia in patients with chronic kidney disease with daprodustat: A report of two cases. EJHaem，5(6)：1335-1339，2024．
Miyazaki T, Kamimura D, Wakamatsu M, Konishi M, Matsumura A, Teshigawara H, Teranaka H, Koyama
S, Takahashi H, Kunimoto H, Enaka M, Hagihara M, Matsumoto K, Yamazaki E, Nakajima H： Rare severe constrictive pericarditis complication in Erdheim-Chester disease: A case report and literature review．J Clin Exp Hematop，64(3)：232-236，2024．
Miyazaki T, Tachibana T, Suzuki T, Izumi A, Fujimaki K, Sato S, Tamai Y, Michishita Y, Suzuki
T, Ishii R, Hirasawa A, Hashimoto C, Kabasawa N, Inoue Y, Ishiyama T, Yamamoto K, Kanamori H, Tanaka M, Nakajima H：Pretransplantation Inflammatory and Nutritional Status in Elderly Allogeneic Hematopoietic Stem Cell Transplantation: Prognostic Value of C-Reactive Protein-to-Albumin Ratio．Transplant Cell Ther，30(4)：400.e1-400.e9，2024．
Nukui J, Tachibana T, Miyazaki T, Tanaka M, Matsumoto K, Ishii Y, Numata A, Nakajima Y,
Matsumura A, Suzuki T, Izumi A, Hirose N, Yamamoto K, Hagihara M, Fujisawa S, Nakajima H： Impact of bone marrow nucleated cell subfractions on transplant outcomes in patients with acute lymphoblastic leukemia．Hematology，29(1)：2424053，2024．
Nukui J, Tachibana T, Miyazaki T, Tanaka M, Matsumoto K, Ishii Y, Numata A, Nakajima Y,
Matsumura A, Suzuki T, Izumi A, Hirose N, Yamamoto K, Hagihara M, Fujisawa S, Kanamori H, Nakajima H：Clinical significance of total nucleated cell count in bone marrow of patients with acute lymphoblastic leukemia who underwent allogeneic hematopoietic stem cell transplantation．Int J Hematol，119(1)：62-70，2024．
Numata A, Sakai R, Kawachi K, Ishiyama Y, Hattori Y, Takasaki H, Yokose T, Nakamura N, Nakajima
H：Clinicopathological and genetic analyses of thyroid large B-cell lymphoma in a Japanese population．J Clin Exp Hematop，64(4)：286-291，2024．
Ohashi T, Kunimoto H, Nukui J, Teshigawara H, Koyama S, Miyazaki T, Hagihara M, Matsumoto K,
Koshimizu E, Tsuchida N, Hamanoue H, Miyatake S, Yachie A, Matsumoto N, Nakajima H：A case of Bloom syndrome manifesting with therapy-related myelodysplastic syndromes harboring a novel BLM gene variant.Int J Hematol,119(5):603-607,2024．
Sakuma T, Fujisawa S, Tanaka M, Hagihara M, Fujita H, Fujimaki K, Katsuki K, Akimoto M, Tanaka
M, Matsumura A, Teshigawara H, Suzuki T, Teranaka H, Nakajima Y, Miyazaki T, Tachibana T, Matsumoto K, Sakai R, Kanamori H, Nakajima H：Prognostic significance of the CFA ratio for newly diagnosed acute myeloid leukemia: A multicenter retrospective study．Hematol Oncol，42(1)：e3228，2024．
Soma S, Murakami K, Fukuchi Y, Kunimoto H, Nakajima H：O-Linked N-Acetylglucosamine Transferase
Ensures Survival of Mouse Fetal Liver Hematopoietic Progenitors Partly by Regulating Bcl-xL and Oxidative Phosphorylation．Stem Cells，42(1)：55-63，2024．
Tachibana T, Tanaka M, Noguchi Y, Najima Y, Sadato D, Harada Y, Tamai Y, Doki N, Nakajima H：
Successful treatment of two cases with Philadelphia- chromosome positive acute lymphoblastic leukemia who relapsed after allogeneic stem cell transplantation and the treatments with novel immunotherapies and ponatinib．Hematology，29(1)：2360843，2024．
Tachibana T, Miyazaki T, Matsumura A, Hagihara M, Tanaka M, Koyama S, Ogusa E, Aoki J, Nakajima
Y, Takahashi H, Suzuki T, Ishii Y, Teshigawara H, Matsumoto K, Hatayama M, Izumi A, Ikuta K, Yamamoto K, Kanamori H, Fujisawa S, Nakajima H：Investigation of biomarkers to predict outcomes in allogeneic hematopoietic stem cell transplantation．Cytotherapy，26(8)：921-929，2024．
Takayama K, Fujisawa S, Sakuma T, Hasegawa K, Katsuki K, Akimoto M, Matsumura A, Nakajima Y,
Miyazaki T, Murase M, Nakajima H：Successful Pregnancy and Delivery After Frozen-thawed Embryo Transfer Following the Third Discontinuation of Tyrosine Kinase Inhibitor in a Woman with Chronic Myeloid Leukemia．Intern Med，63(23)：3233-3236，2024．
Tokunaga M, Takahashi H, Hirose N, Hibino Y, Teranaka H, Washimi K, Okubo Y, Hiroshima Y,
Tanaka M, Sakai R：SMARCA4-deficient epithelioid sarcoma revealed by comprehensive genomic profiling, leading to a notable response by nivolumab treatment. Int Cancer Conf J， 14(1):1-6，2024．
